On the Admissibility of ‘Biological Equivalence Tests‘ During the Patent Term 
for Obtaining a Regulatory Approval for Patented Drugs by Third Parties - A 
Study in German and Comparative Law

Straus, Joseph

Local TagsRelease HistoryDetailsSummary

On the Admissibility of ‘Biological Equivalence Tests‘ During the Patent Term for Obtaining a Regulatory Approval for Patented Drugs by Third Parties - A Study in German and Comparative Law

Straus, J. (1998). On the Admissibility of ‘Biological Equivalence Tests‘ During the Patent Term for Obtaining a Regulatory Approval for Patented Drugs by Third Parties - A Study in German and Comparative Law. AIPPI Journal of the Japanese Group, 211-246.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-C5AD-A Version Permalink: https://hdl.handle.net/11858/00-001M-0000-0014-C5AE-8

Genre: Journal Article

Files

show Files

Locators

show

Creators

show

hide

Creators:
Straus, Joseph¹, Author

Affiliations:
1Max Planck Institute for Foreign and International Patent, Copyright and Competition Law, ou_830549

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 1998

Publication Status: Issued

Pages: -

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: -

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: AIPPI Journal of the Japanese Group

Source Genre: Journal

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: - Sequence Number: - Start / End Page: 211 - 246 Identifier: ISSN: 0385-8863
ZDB: 704841-5